We will get a conditional eGFR at circa week 70 (maybe mid Nov 24 ?), is how I see it - snippet below from Dimerix Website. But if Part 2 is positive, we have the potential to submit for a fast-tracked regulatorypathway to approval given the Orphan Drug Designation for DMX-200 in both the US and Europe for FSGS.
- Forums
- ASX - By Stock
- DXB
- Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma
Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma, page-130
-
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
57.5¢ |
Change
0.020(3.60%) |
Mkt cap ! $318.8M |
Open | High | Low | Value | Volume |
57.0¢ | 59.5¢ | 56.5¢ | $803.0K | 1.385M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 12067 | 57.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
58.0¢ | 59357 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 12066 | 0.575 |
5 | 248629 | 0.570 |
5 | 55644 | 0.565 |
14 | 440486 | 0.560 |
5 | 89332 | 0.555 |
Price($) | Vol. | No. |
---|---|---|
0.580 | 38357 | 3 |
0.585 | 14729 | 3 |
0.590 | 34477 | 4 |
0.595 | 54619 | 4 |
0.600 | 57450 | 5 |
Last trade - 11.39am 20/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online